Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Sweden / NCT07605585
Active, not recruiting Not applicable

Sensory Neurography and S2PD, a Test-Retest Study

NCT07605585 · tracked via the Priya Life Science Sweden tracker
Sponsor
Karolinska Institutet
Phase
Not applicable
Started
2025-12-04
Last updated
2026-05-26

Condition(s) studied

Reliability of Sensory Neurography and S2PD

Investigational drug(s) / intervention(s)

S2PDSensory neurography

S2PD: see section "study description"

Sensory neurography: see section "study description"

Study summary

This study was conducted as a test-retest investigation to assess the reliability of the methods prior to a planned study on the same topic. Ten volunteer participants were recruited from among employees at Sodersjukhuset (South General Hospital). The radial aspects of the second and fourth digits on both hands were examined using static two-point discrimination (S2PD) and sensory neurography on two separate occasions. The results from the two separate measurements will be analysed with an Intra Class Coefficient analysis and a Bland-Altman test.

Eligibility

Sex
ALL
Min age
20 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Age \>20 * Age \<60 Exclusion Criteria: * Neurologic disease * Dementia * Cognitive disability * Severe psychiatric disorder (not be able to participate) * Ongoing drug abuse * Not understanding swedish language * History of carpal tunnel syndrome * Negative experience of electric stimulation

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Hand Surgery, Södersjukhuset Hospital, Stockholm, Sweden Stockholm Sweden

More Karolinska Institutet trials in Sweden

Diagnostic and Prognostic Salivary Biomarkers in Chronic Muscle Pain Active, not recruiting
Brain Connectivity Marker for Alzheimer's Disease Recruiting
Feasibility, Acceptability, and Preliminary Effects of ISTDP for Personality Disorders in a Specialized Psychiatric Clinic Enrolling by invitation
Health-related Quality of Life in Chiari Malformation Type 1 - A National Cross-Sectional Patient Survey Enrolling by invitation
Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07605585 on ClinicalTrials.gov ↗ ← All trials in Sweden